This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fabbro, D. Articles by Eppenberger, U. Search for Related Content PubMed PubMed Citation Articles by Fabbro, D. Articles by Eppenberger, U.

Epidermal Growth Factor Binding and Protein Kinase C Activities in Human Breast Cancer Cell Lines: Possible Quantitative Relationship¹

Laboratory of Biochemistry-Endocrinology, Department of Research, and Department of Gynecology and Obstetrics, University Clinic Medical School, CH-4031 Basel, Switzerland

Quantitative polyacrylamide gel electrophoresis analysis of Ca²⁺, phospholipid-dependent protein kinase (PKC) of human mammary tumor cell lines (MCF-7, ZR-75, T-47-D, MDA-MB-231, BT-20, and HBL-100) revealed that 80% of the total cellular PKC resided in the cytosol. The tumor cells with no detectable levels of estrogen receptors (MDA-MB-231, HBL-100, and BT-20 cells) exhibited significantly larger (P < 0.001) cytosolic PKC activities than those cells that contained estrogen receptors (MCF-7, T-47-D, and ZR-75 cells). In addition, in estrogen receptor-negative cell lines, relatively high levels of specific low-affinity (appearent K_d = 700 pM) epidermal growth factor (EGF) binding activities were found as compared with estrogen receptor-positive cells with significantly (P < 0.001) lower levels of specific high-affinity (apparent K_d = 90 pM) EGT binding. A significant positive correlation (P < 0.01) was observed between the number of EGF receptor (R_s = 0.50) and/or the EGF receptor dissociation constants (R_s = 0.78) with the cytosolic PKC activity levels. These data indicate that, in human breast cancer cells, a positive relationship may exist between PKC activity, estrogen, and EGF receptors.

¹ This work was supported in part by the Swiss Cancer League, Grant FOR-249.AK.83(6), and by the Swiss National Science Foundation, Grant 3.409.0.83, as well as by CIBA-GEIGY Ltd., Basel, Switzerland.

² To whom requests for reprints should be addressed at Universitäts-Frauenklinik, Laboratorien, CH-4031 Basel, Switzerland.

Received 5/14/85. Revised 9/12/85. Revised 1/31/86. Accepted 2/11/86.

This article has been cited by other articles:

				J W Assender, J M W Gee, I Lewis, I O Ellis, J F R Robertson, and R I Nicholson Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer J. Clin. Pathol., November 1, 2007; 60(11): 1216 - 1221. [Abstract] [Full Text] [PDF]

				A. P. Vamvakidou, M. J. Mondrinos, S. P. Petushi, F. U. Garcia, P. I. Lelkes, and A. Tozeren Heterogeneous Breast Tumoroids: An In Vitro Assay for Investigating Cellular Heterogeneity and Drug Delivery J Biomol Screen, February 1, 2007; 12(1): 13 - 20. [Abstract] [PDF]

				C. F. Basil, Y. Zhao, K. Zavaglia, P. Jin, M. C. Panelli, S. Voiculescu, S. Mandruzzato, H. M. Lee, B. Seliger, R. S. Freedman, et al. Common cancer biomarkers. Cancer Res., March 15, 2006; 66(6): 2953 - 2961. [Abstract] [Full Text] [PDF]

				B. D. Boyan, V. L. Sylvia, T. Frambach, C. H. Lohmann, J. Dietl, D. D. Dean, and Z. Schwartz Estrogen-Dependent Rapid Activation of Protein Kinase C in Estrogen Receptor-Positive MCF-7 Breast Cancer Cells and Estrogen Receptor-Negative HCC38 Cells Is Membrane-Mediated and Inhibited by Tamoxifen Endocrinology, May 1, 2003; 144(5): 1812 - 1824. [Abstract] [Full Text] [PDF]

				V. G. Keshamouni, R. R. Mattingly, and K. B. Reddy Mechanism of 17-beta -Estradiol-induced Erk1/2 Activation in Breast Cancer Cells. A ROLE FOR HER2 AND PKC-delta J. Biol. Chem., June 14, 2002; 277(25): 22558 - 22565. [Abstract] [Full Text] [PDF]

				W. G.R. Angus, M. C. Larsen, and C. R. Jefcoate Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status Carcinogenesis, June 1, 1999; 20(6): 947 - 955. [Abstract] [Full Text] [PDF]

				M. B. Martin, P. Garcia-Morales, A. Stoica, H. B. Solomon, M. Pierce, D. Katz, S. Zhang, M. Danielsen, and M. Saceda Effects of 12-O-Tetradecanoylphorbol-13-acetate on Estrogen Receptor Activity in MCF-7 Cells J. Biol. Chem., October 20, 1995; 270(42): 25244 - 25251. [Abstract] [Full Text] [PDF]